You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 71 No. 2, February 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF EARLY SYPHILIS

Results with Penicillin G Procaine and Two Per Cent Aluminum Monostearate

JOHN C. CUTLER, M.D.; SIDNEY OLANSKY, M.D.; ELEANOR V. PRICE

AMA Arch Derm. 1955;71(2):239-244.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE of penicillin G procaine in oil with 2% aluminum monostearate (PAM) in the treatment of syphilis, and its continued extensive use have justified the early hopes held for it. Although newer preparations such as benzathine penicillin G appear to have certain advantages over the earlier preparation, there is little question of the value of PAM in the management of syphilis. It seems appropriate at this time, therefore, to review the experience of the Venereal Disease Program of the Public Health Service with this preparation.

Through the Public Health Service's Venereal Disease Research Laboratory and the patient material made available first at the various rapid treatment centers and later at the prevention and control centers, the Program has had excellent opportunity to study and evaluate PAM. Observation of sufficiently large groups of patients treated by various schedules had enabled it to arrive at valid comparisons of . . . [Full Text PDF of this Article]


Author Affiliations

Washington, D. C.; Chamblee, Ga.; Washington, D. C.

From the Venereal Disease Program, Division of Special Health Services, United States Public Health Service (Dr. Cutler, Senior Surgeon, Venereal Disease Program; Dr. Olansky, Director, Venereal Disease Research Laboratory; Mrs. Price, Statistician, Venereal Disease Program).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.